Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Prudential PLC Regulatory Filings 2019

Nov 6, 2019

4668_rns_2019-11-06_b665906c-d2b0-4b73-82f2-fae8b9d7457f.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3868S

Prudential PLC

06 November 2019

Prudential plc

--------------------

Application has been made to the Financial Conduct Authority and the London Stock Exchange for a total of 2,700,000 ordinary shares of 5 pence each ("Shares") to be admitted to the Official List.

These Shares are being reserved under a block listing and will be issued as a result of exercising of future share options pursuant to the following share schemes:

Schemes Shares
Prudential Savings-Related Share Option Scheme 1,750,000
Prudential International Savings-Related Share Option Scheme for Non-Employees 950,000

The admission date for these Shares is expected to be Thursday 7 November 2019. When issued, these Shares will rank pari passu with the existing ordinary shares.

Prudential plc is not affiliated in any manner with Prudential Financial, Inc., a company whose principal place of business is in the United States of America or with the Prudential Assurance Company, a subsidiary of M&G plc, a company incorporated in the United Kingdom.

Name of contact and telephone number for queries

Jennie Webb, Share Plans and Share Capital Manager, +44 (0)20 3977 9750

Name of duly authorised officer of issuer responsible for making notification

Chris Smith, Deputy Group Secretary, +44 (0)20 3977 9639

Date of notification

6 November 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ALSBABPTMBBMBTL